Law360, Philadelphia (October 8, 2019, 5:36 PM EDT) -- A Pennsylvania company pushed a clot-stopping vein filter onto the market despite a clinical study showing the product was prone to failure, a jury heard during opening arguments Tuesday in a trial over injuries suffered by a woman implanted with one of the devices.
David Matthews, an attorney with Matthews & Associates representing Tracy Reed-Brown, told jurors in Philadelphia that Rex Medical LP had pressed doctors who reported problems with the filter to rethink whether complications experienced by their patients during a clinical trial were actually a result of problems with the device.
"They were heavy-handed with the doctors and went...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!